High vaccine effectiveness against coronavirus disease 2019 (COVID-19) and severe disease among residents and staff of long-term care facilities in Norway, November 2020–June 2021...

by Jostein Starrfelt, Anders Skyrud Danielsen, Oliver Kacelnik, Anita Wang Børseth, Elina Seppälä, Hinta Meijerink
Published 2022-01-01

Effectiveness of BNT162b2 vaccine against SARS-CoV-2 Delta and Omicron infection in adolescents, Norway, August 2021 to January 2022

by Lamprini Veneti, Jacob Dag Berild, Sara Viksmoen Watle, Jostein Starrfelt, Margrethe Greve-Isdahl, Petter Langlete, Håkon Bøås, Karoline Bragstad, Olav Hungnes, Hinta Meijerink
Published 2023-05-01

Age and product dependent vaccine effectiveness against SARS-CoV-2 infection and hospitalisation among adults in Norway: a national cohort study, July–November 2021

by Jostein Starrfelt, Anders Skyrud Danielsen, Eirik Alnes Buanes, Lene Kristine Juvet, Trude Marie Lyngstad, Gunnar Øyvind Isaksson Rø, Lamprini Veneti, Sara Viksmoen Watle, Hinta Meijerink
Published 2022-09-01

No difference in risk of hospitalization between reported cases of the SARS-CoV-2 Delta variant and Alpha variant in Norway

by Lamprini Veneti, Beatriz Valcarcel Salamanca, Elina Seppälä, Jostein Starrfelt, Margrethe Larsdatter Storm, Karoline Bragstad, Olav Hungnes, Håkon Bøås, Reidar Kvåle, Line Vold, Karin Nygård, Eirik Alnes Buanes, Robert Whittaker
Published 2022-02-01